Condition
Venous Insufficiency (Chronic)(Peripheral)
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed4
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07699796Phase 4Completed
Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation
NCT07577141Not Yet Recruiting
Impact of Chronic Venous Insufficiency on Outcomes After Total Knee Arthroplasty
NCT06054737CompletedPrimary
Chronic Venous Insufficiency and Balneotherapy
NCT04180137Not ApplicableCompleted
Management of Endothelial Dysfunction in Patients With Chronic Venous Insufficiency After Endovenous Surgical Procedure
NCT04758728Not ApplicableCompletedPrimary
Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping
Showing all 5 trials